Articles published by AB Newswire
ATNM-400 Targets B7-H3 and Is Being Studied in a Phase 1 Clinical Trial in South Africa
December 08, 2025
Via AB Newswire
Tickers
ATNM
Actinium Pharmaceuticals Advances ATNM-400 B7-H3 Candidate Into Phase 1 Clinical Trial in South Africa
December 08, 2025
Via AB Newswire
Tickers
ATNM
Cycle Carpentry Give Back To East Bridgewater Community
December 08, 2025
Via AB Newswire
Topics
Bonds
Glimmer Goddess Marks Decade of Clean Beauty Innovation as Holiday Demand Surges for Transparent Skincare
December 08, 2025
Via AB Newswire
Tickers
AMZN
Safe Android APK Downloads Now Available
December 06, 2025
Via AB Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.